Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
AOD 9604 is a new peptide therapy with all the medical weight loss benefits and none of the side effects
Based on current clinical evidence, the rough ordering from largest to smallest weight-loss effect is: Tirzepatide highest average weight loss Semaglutide significant weight loss Tesamorelin moderate weight loss, primarily through visceral fat reduction AOD-9604 primarily body composition effects MOTS-c primarily metabolic and energy effects rather than pure weight reduction AOD-9604 and MOTS-c are generally not considered replacements for GLP-1 medications in patients seeking substantial weight reduction
Every batch is supported by a downloadable COA issued by Liquilabs s.r.o
This makes it a potentially safer option for individuals concerned about insulin sensitivity or diabetes risk
This finding has important safety implications, as elevated IGF-1 levels associated with full GH therapy raise concerns about increased cancer risk, particularly for individuals with pre-existing malignancies or strong family histories
US$ 22.41
US$ 25.56
US$ 26.19
US$ 21.21
US$ 29.39